Delivery Order SPE2DX22D0029-SPE2D826F02LL
- Not listed
- This delivery order, awarded to AmerisourceBergen Drug Corp on October 6, 2025, represents a competitive contract valued at $20,830.29 under a firm fixed-price arrangement with an ultimate completion date of October 7, 2025. The contract is issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. As a non-set-aside award, this delivery order was...
- This delivery order, awarded to AmerisourceBergen Drug Corp on October 8, 2025, represents a $10,173.33 firm fixed-price contract funded by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded without set-aside designation and will be performed at...
- This delivery order, awarded to AmerisourceBergen Drug Corp on October 13, 2025, represents a competitive federal contract valued at $16,586.56 with an ultimate completion date of October 14, 2025. The contract is a firm fixed price delivery order issued under the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected through open competition with no set-aside designation....
- This delivery order, awarded October 17, 2025, represents a $3,279.24 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99M through December 2026. This underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,038.72 on October 6, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is not set-aside restricted, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, will...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $116,799.91 to AmerisourceBergen Drug Corp on October 18, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The company, headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, with a ceiling value of $1,262.15. This firm fixed price delivery order, which is a child contract under a larger indefinite delivery vehicle, carries an ultimate completion date of October 16, 2025. The award was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical supply...
- This delivery order, awarded on October 15, 2025, to AmerisourceBergen Drug Corp represents a $11,340.40 firm fixed-price contract under the company's existing Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is not set-aside and was competitively awarded. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025. The delivery order falls under...
- This delivery order, awarded on October 5, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order has a ceiling value of $1,036.80 and is structured as a firm fixed price contract with no set-aside designation, indicating competitive award authority. The contract is funded through the Medical Supply Chain, a...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $12,347.40 to AmerisourceBergen Drug Corp on October 14, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999. The award was competitively made with no set-aside...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F02LLDelivery Order
This delivery order, awarded to AmerisourceBergen Drug Corp on October 18, 2025, represents a $12,505.44 firm fixed-price contract with an ultimate completion date of October 20, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order represents one transaction within that expansive contract framework, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 10/18/25 |